General Information of Drug (ID: DMY3Q58)

Drug Name
PMID29671355-Compound-65a
Drug Type
Small molecular drug
Structure
3D MOL 2D MOL
#Ro5 Violations (Lipinski): 0 Molecular Weight (mw) 303.4
Logarithm of the Partition Coefficient (xlogp) 2.9
Rotatable Bond Count (rotbonds) 8
Hydrogen Bond Donor Count (hbonddonor) 3
Hydrogen Bond Acceptor Count (hbondacc) 4
Chemical Identifiers
Formula
C16H21N3OS
IUPAC Name
N-[5-(quinolin-8-ylamino)pentyl]-2-sulfanylacetamide
Canonical SMILES
C1=CC2=C(C(=C1)NCCCCCNC(=O)CS)N=CC=C2
InChI
InChI=1S/C16H21N3OS/c20-15(12-21)18-10-3-1-2-9-17-14-8-4-6-13-7-5-11-19-16(13)14/h4-8,11,17,21H,1-3,9-10,12H2,(H,18,20)
InChIKey
WCTPLVYFIGGBJC-UHFFFAOYSA-N
Cross-matching ID
PubChem CID
126720707
TTD ID
D0F3TB

Molecular Interaction Atlas of This Drug


Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
Histone deacetylase 1 (HDAC1) TT6R7JZ HDAC1_HUMAN Inhibitor [1]
Histone deacetylase 6 (HDAC6) TT5ZKDI HDAC6_HUMAN Inhibitor [1]
Molecular Interaction Atlas (MIA) Jump to Detail Molecular Interaction Atlas of This Drug

Molecular Expression Atlas of This Drug

Molecule Name Molecule Type Gene Name p-value Fold-Change Z-score
Histone deacetylase 1 (HDAC1) DTT HDAC1 1.54E-06 0.66 4.44
Histone deacetylase 6 (HDAC6) DTT HDAC6 6.91E-02 0.27 0.79
Molecular Expression Atlas (MEA) Jump to Detail Molecular Expression Atlas of This Drug

References

1 HDAC inhibitors: a 2013-2017 patent survey.Expert Opin Ther Pat. 2018 Apr 19:1-17.